3-对甲苯基-5-(4′-硝基-2′-羧基苯偶氮)-2-硫代-4-噻唑啉酮的合成及用于铜的荧光光度测定

本文报道了新荧光试剂3-对甲苯基-5-（4’-硝基-2‘-羧基苯偶氮）-2-硫代-4-噻唑啉酮（MPNCPATTN）的合成。通过元素分析、红外光谱，核磁共振氢谱和质谱确证了其结构。在pH5．6时，它与铜（Ⅱ）形成稳定的荧光络合物，在λex／λem=308nm／403nm处产生强烈荧光，其荧光强度与铜（Ⅱ）的浓度在6．28×10－9～9．44×10-7mo1／L范围内呈线性关系，检测限为0.399μg／L的铜（Ⅱ）。测定了人发中的痕量铜，结果满意。     

希土盐与三种α-氨基酸配合物的合成和化学键性质的研究

合成了１４种希土氨基酸的固态配合物，并用反射电子光谱对其进行了表征。根据电子反射光谱数据，对每个配合物的Ｓｌａｔｅｒ－Ｃｏｎｄｏｎ参量（Ｆ２、Ｆ４、Ｆ６）和Ｌａｎｄｅ参量（ζ４５）、Ｎｅｐｈａｌａｎｘｅｔｅ比率（β）进行了计算，还计算了平均共价参数（δ）、成键参数（ｂ１／２）及Ｓｌａｔｅｒ径向积分比值（Ｆ４／Ｆ２与Ｆ６／Ｆ２）。结果表明：在这些配合物中ＲＥ３＋与三种α－氨基酸间配位键存在一定程度的共价性     

4－硝基邻苯二甲酸根桥联双核钴(Ⅱ)配合物的合成、磁性及抗癌活性

研究桥联多核配合物的磁性不仅有助于了解桥联多核配合物在生物体内所起的各种生物功能,而且可为分子铁磁体的设计和合成提供信息.某些过渡金属配合物已显示了体外抗艾滋病和抗癌活性,有关桥联多核配合物在这方面的研究甚少.     

α－葡萄糖基甜菊糖的酶促合成反应（Ⅱ）

研究了以球形纤维素弱阴离子交换剂作载体，固定化葡萄糖基转移酶ＧＴ－１转化甜菊糖为α－葡萄糖基甜菊糖反应的各种影响因素。结果表明，甜菊糖的酶促转化到达一定程度后，继续增大酶用量及淀粉用量，对转化结果没有太多改善，固定化酶重复使用８次，活力下降较少，说明固定化效果良好。     

水、低碳醇与环己烷间的液-液平衡的测定与推算

用浊点法与折光分析相结合的方法测定了水-异丁醇-环己烷三元系(体系Ⅰ)30℃下的液-液平衡相图。用色谱分析方法测定了水-若干低碳醇(体系Ⅱ)及水-低碳醇-环己烷(体系Ⅲ)的液-液平衡关系。用UNIQUAC模型预测,实测值与计算值平均偏差对体系Ⅰ为0.49%(mol,下同),对体系Ⅱ为O.71%。体系Ⅲ为1.07%。     

木糖腺苷类似物的合成

糖部分修饰的核苷类似物,作为有效的抗肿瘤及抗病毒药物,受到广泛的注意。但木糖系列则研究得较少。据报道木糖苷也显示抗肿瘤活性,木糖腺苷虽呈一定的抗肿瘤活性,但毒性较大。为了进一步研究木糖苷类似物的药理作用,我们合成了一系列8-取代的β-D-呋喃型木糖基腺嘌呤。     

三正辛胺修饰电极伏安测定痕量金的研究

用化学修饰电极伏安测定痕量金,Kalcher K等曾采用阴离子交换剂碳糊修饰电极及打萨宗碳糊修饰电极检测100～300μg/L的金。本文采用三正辛胺(TOA)修饰玻碳电极,在1.5 mol/L介质中,Au(Ⅲ)在+0.16 V(vs SCE)处有一灵敏的不可逆还原峰。检出限为0.1μg/L。灵敏度比文献方法高千倍。Au(Ⅲ)浓度在5×10~(-7)～5×10~(-9)mol/L范围内峰高与浓度     

Development and validation of HPLC methods for enantioseparation of mirtazapine enantiomers at analytical and semipreparative scale using polysaccharide chiral stationary phases

Novel HPLC methods were developed for the analytical and semipreparative resolution of new antidepressant drug mirtazapine enantiomers. At analytical scale, the separation of the mirtazapine enantiomers was investigated using both cellulose and amylose tris(3,5-dimethylphenylcarbamate) (CDMPC and ADMPC) chiral stationary phases under normal-phases and polar organic modes. Good baseline enantioseparation was achieved using cellulose tris(3,5-dimethylphenylcarbamate) chiral stationary phases under both normal-phases and polar organic modes. Furthermore, the elution order of mirtazapine enantiomic pairs was found reversed by changing the stationary phase from the amylose-based ADMPC–CSPs to its cellulose-based counterpart, CDMPC–CSPs. The validation of the analytical methods including linearity, limit of detection (LOD), limit of quantification (LOQ), recovery and precision, together with the semipreparative resolution of mirtazapine racemate were carried out using cellulose tris(3,5-dimethylphenylcarbamate) chiral stationary phases and methanol as mobile phase without any basic additives under polar organic mode. At analytical scale, the elution times of both enantiomers were less than 6 min at normal temperature and 1.0 ml/min, with the separation factor () 1.99 and the resolution factor (Rs) 3.56. Then, the analytical methods were scaled up to semipreparative loading to obtain small quantities of both mirtazapine enantiomers. At semipreparative scale, about 16 mg/h enantiomers could be isolated and elution times of both enantiomers were less than 10 min at 2.0 ml/min. To increase the throughput, the technique of boxcar injections was used. One enantiomer ((−)-(R)-mirtazapine) was isolated with purity of >99.9% e.e. and >98.0% yield and another ((+)-(S)-mirtazapine) was isolated with purity of >97.0% e.e. and >99.0% yield. In addition, optical rotation and circular dichroism (CD) spectroscopy of both mirtazapine enantiomers isolated were also investigated.